Trial Profile
Efficacy and safety of lenalidomide in older patients with newly diagnosed, standard risk multiple myeloma
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2014
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Dexamethasone; Prednisone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 26 Sep 2014 New trial record